🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/02/2005 | 27,15 | 27,33 | 26,75 | 27,11 | -0,18% | 2,14% | 13.747.245 |
| 02/02/2005 | 26,65 | 27,34 | 26,58 | 27,16 | +2,26% | 2,83% | 14.414.716 |
| 01/02/2005 | 26,77 | 26,99 | 26,51 | 26,56 | -0,78% | 1,82% | 17.799.337 |
| 31/01/2005 | 26,74 | 26,89 | 26,36 | 26,77 | +0,11% | 2,00% | 31.296.843 |
| 28/01/2005 | 29,90 | 29,90 | 26,22 | 26,74 | -10,13% | 12,29% | 59.899.802 |
| 27/01/2005 | 29,69 | 29,85 | 29,41 | 29,75 | +0,03% | 1,48% | 7.566.350 |
| 26/01/2005 | 29,58 | 29,90 | 29,58 | 29,74 | +0,71% | 1,10% | 7.558.700 |
| 25/01/2005 | 28,86 | 29,79 | 28,63 | 29,53 | +3,69% | 4,03% | 12.904.967 |
| 24/01/2005 | 29,10 | 29,25 | 28,48 | 28,48 | -1,68% | 2,62% | 10.854.136 |
| 21/01/2005 | 29,35 | 29,38 | 28,83 | 28,97 | -1,20% | 1,89% | 7.498.859 |
| 20/01/2005 | 29,77 | 29,78 | 29,24 | 29,32 | -0,93% | 1,83% | 8.156.270 |
| 19/01/2005 | 29,86 | 30,06 | 29,56 | 29,60 | -0,89% | 1,66% | 8.384.105 |
| 18/01/2005 | 29,46 | 29,97 | 29,27 | 29,87 | +1,39% | 2,36% | 8.472.346 |
| 14/01/2005 | 29,01 | 29,51 | 29,01 | 29,46 | +0,72% | 1,74% | 7.512.902 |
| 13/01/2005 | 29,58 | 29,63 | 29,10 | 29,25 | -1,38% | 1,77% | 8.366.708 |
| 12/01/2005 | 29,82 | 29,91 | 29,54 | 29,66 | -0,29% | 1,25% | 10.428.124 |
| 11/01/2005 | 30,04 | 30,04 | 29,66 | 29,74 | -1,05% | 1,27% | 7.896.890 |
| 10/01/2005 | 29,70 | 30,06 | 29,31 | 30,06 | +1,19% | 2,51% | 8.521.917 |
| 07/01/2005 | 30,08 | 30,15 | 29,69 | 29,70 | -1,36% | 1,52% | 10.808.758 |
| 06/01/2005 | 30,06 | 30,29 | 29,90 | 30,11 | +0,70% | 1,27% | 7.538.788 |
| 05/01/2005 | 29,70 | 30,20 | 29,63 | 29,90 | +0,67% | 1,93% | 16.589.211 |
| 04/01/2005 | 30,03 | 30,15 | 29,59 | 29,70 | -0,42% | 1,87% | 13.575.792 |
| 03/01/2005 | 30,52 | 30,75 | 29,56 | 29,83 | -2,74% | 3,91% | 18.835.390 |
| 31/12/2004 | 30,75 | 30,91 | 30,67 | 30,67 | -0,25% | 0,78% | 6.425.707 |
| 30/12/2004 | 30,80 | 30,88 | 30,67 | 30,74 | -0,06% | 0,68% | 7.238.850 |
| 29/12/2004 | 30,77 | 30,94 | 30,53 | 30,76 | +0,12% | 1,30% | 7.585.738 |
| 28/12/2004 | 30,52 | 30,82 | 30,51 | 30,73 | +0,78% | 1,03% | 8.825.732 |
| 27/12/2004 | 30,82 | 31,01 | 29,95 | 30,49 | -1,08% | 3,44% | 10.156.063 |
| 23/12/2004 | 30,91 | 31,16 | 30,72 | 30,82 | +0,25% | 1,45% | 12.618.863 |
| 22/12/2004 | 30,53 | 30,91 | 30,52 | 30,74 | +0,75% | 1,28% | 14.574.222 |